MYL: Subsidiary obtains drug registration certificate

MYL announced that its subsidiary Jiangxi MYL Meikang Pharmaceutical Co., Ltd. has received the Drug Registration Certificate for Olopatadine Hydrochloride Eye Drops issued by the National Medical Products Administration. Olopatadine Hydrochloride Eye Drops are used to treat eye itching associated with allergic conjunctivitis